AstraZeneca e-mails show debate on Seroquel risks

TRENTON, N.J. (AP) -- Marketing executives at British drugmaker AstraZeneca PLC for years blocked efforts by company scientists to raise concerns antipsychotic drug Seroquel caused weight gain and other problems, saying that would harm sales, plaintiff lawyers say....

Read the whole article on AP Health

More from AP Health